title: Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy.
authors.affiliation: Klinik für Dermatologie, Venerologie und Allergologie Allergie-Centrum-Charité (CCM) Charité- Universitätsmedizin Berlin Charitéplatz, 10117 Berlin Germany. h.lee@charite.de
authors.forename: H
authors.initials: H
authors.lastname: Lee
authors.forename: C
authors.initials: C
authors.lastname: Roediger
authors.forename: A
authors.initials: A
authors.lastname: Bauer
authors.forename: T
authors.initials: T
authors.lastname: Zuberbier
authors.forename: M
authors.initials: M
authors.lastname: Worm
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000628:therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014862:Wasp Venoms / Q000008:administration & dosage*
chemical_list: D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D014862:Wasp Venoms; D011241:Prednisone